# A Study of R-mini-MCOP in the Treatment of Elderly, Previously Untreated DLBCL

> **NCT06921044** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Xiaohui He** · enrollment: 33 (estimated)

## Conditions studied

- Diffuse Large B-Cell Lymphoma

## Interventions

- **DRUG:** R-miniMCOP:Rituximab / Mitoxantrone Liposome / Cyclophosphamide / Vincristine / Prednisone

## Key facts

- **NCT ID:** NCT06921044
- **Lead sponsor:** Xiaohui He
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04-16
- **Primary completion:** 2026-02-01
- **Final completion:** 2027-03-01
- **Target enrollment:** 33 (ESTIMATED)
- **Last updated:** 2025-04-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06921044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06921044, "A Study of R-mini-MCOP in the Treatment of Elderly, Previously Untreated DLBCL". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06921044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*